Bal Pharma Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: BALPHARMA BSE: 524824

₹109.53

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #125 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Bal Pharma Limited (this stock)	174	21.7	7.7%	30.9%	1.10%	22	65	87

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹326 Cr

EV / EBITDA

9.1x

EV / Sales

0.98x

Market cap / Sales

0.52x

Earnings yield

4.60%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 89 Cr, up 33.9% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 1 Cr, up 259.4% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	88	1	1	₹0.7300
March 31, 2026	84	3	4	₹2.6000
Dec. 31, 2025	87	2	2	₹1.2200
Sept. 30, 2025	74	1	1	₹0.4900
June 30, 2025	66	0	0	₹0.2000
March 31, 2025	82	3	6	₹3.5100
Dec. 31, 2024	73	1	1	₹0.7300
Sept. 30, 2024	75	2	1	₹0.7600
June 30, 2024	73	2	2	₹1.1100
March 31, 2024	95	7	6	₹4.1600
Dec. 31, 2023	81	2	1	₹0.8000
Sept. 30, 2023	92	2	2	₹1.0200
June 30, 2023	70	2	1	₹0.7600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	89	84	88	75	66	83	74	75	74	97	82	93	71
Operating revenue	88	84	87	74	66	82	73	75	73	95	81	92	70
Other income	0	-0	0	1	1	1	1	0	1	2	0	0	0
Operating expenses	80	73	78	68	59	74	65	67	66	84	74	85	63
Operating profit	8	11	10	6	6	8	8	7	7	10	8	8	7
Operating profit margin	9.0%	12.7%	11.1%	7.8%	9.4%	9.6%	10.6%	10.0%	9.7%	10.9%	9.4%	8.3%	9.8%
Depreciation	3	3	3	2	3	2	2	2	2	2	3	2	2
Interest	4	4	5	4	4	4	5	4	4	4	4	4	4
Exceptional items, gain / (loss)	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit before tax	1	3	2	1	0	3	1	2	2	7	2	2	2
Tax	—	-0	—	—	—	-3	0	0	0	0	0	1	0
Net profit	1	—	2	1	0	—	1	1	2	6	1	2	1
EPS	0.73	2.60	1.22	0.49	0.20	3.51	0.73	0.76	1.11	4.16	0.80	1.02	0.76
Net profit (TTM)	—	—	—	—	—	—	10	10	11	10	6	6	6
EPS (TTM)	5.04	4.51	5.42	4.93	5.20	6.11	6.76	6.83	7.09	6.74	3.93	4.07	3.77

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	311	—	—
March 31, 2025	302	6	8
March 31, 2024	339	12	10
March 31, 2023	303	9	6

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	0.8%	4.4%	313^†	305^†	342^†	305^†	287^†	252^†	226^†	211^†	234^†
Operating revenue	0.8%	4.5%	311	302	339	303	280^†	249^†	223^†	210^†	231^†
Other income	—	—	2^†	3^†	3^†	2^†	6^†	3^†	3^†	2^†	3^†
Operating expenses	—	—	279^†	272^†	306^†	277^†	257^†	223^†	203^†	187^†	205^†
Operating profit	7.4%	4.1%	32^†	30^†	32^†	26^†	23^†	26^†	20^†	23^†	26^†
Operating profit margin	—	—	10.4%^†	10.0%^†	9.6%^†	8.6%^†	8.2%^†	10.6%^†	9.1%^†	10.9%^†	11.1%^†
Depreciation	—	—	11^†	9^†	8^†	7^†	7^†	7^†	6^†	7^†	6^†
Interest	—	—	17^†	17^†	15^†	12^†	10^†	12^†	13^†	9^†	8^†
Exceptional items, gain / (loss)	—	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	-9.4%	-8.3%	6^†	6	12	9	12^†	10^†	4^†	9^†	8^†
Tax	—	—	—	-2^†	2^†	2^†	3^†	1^†	-2^†	3^†	3^†
Net profit	—	—	—	8	10	6	9^†	9^†	7^†	6^†	5^†
EPS	4.4%	-6.8%	4.51^†	6.11^†	6.74^†	3.96^†	6.20^†	6.41^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 19	Mar 18	Mar 17
Operating margin	10.4%^†	10.0%^†	9.6%^†	8.6%^†	8.2%^†	10.6%^†	9.1%^†	10.9%^†	11.1%^†
EBIT margin	7.5%^†	7.5%^†	8.1%^†	6.8%^†	8.0%^†	8.7%^†	7.6%^†	8.5%^†	7.2%^†
PBT margin	2.0%^†	1.9%	3.6%	2.8%	4.3%^†	3.9%^†	1.9%^†	4.1%^†	3.5%^†
Net margin	—	2.6%	3.0%	2.0%	3.3%^†	3.6%^†	2.9%^†	2.8%^†	2.2%^†
Interest coverage	1.38x^†	1.34x^†	1.79x^†	1.70x^†	2.16x^†	1.82x^†	1.33x^†	1.93x^†	1.95x^†
Dividend payout	26.6%^†	19.6%^†	14.8%^†	25.3%^†	16.1%^†	0.0%^†	—	—	—
Earnings retention	73.4%^†	80.4%^†	85.2%^†	74.7%^†	83.9%^†	100.0%^†	—	—	—
Current ratio	—	1.16x	—	—	—	—	—	—	—
Quick ratio	—	0.68x	—	—	—	—	—	—	—
Debt to equity	1.48x	1.46x	—	—	—	—	—	—	—
Return on equity	—	7.9%	—	—	—	—	—	—	—
Return on assets	—	2.2%	—	—	—	—	—	—	—
Return on capital employed	—	16.5%^†	—	—	—	—	—	—	—
Asset turnover	—	0.86x	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2025	20	-15	-8	19	2
March 31, 2024	33	3	24	-10	44
March 31, 2023	-9	-18	0	0	-9
March 31, 2022	18	31	0	0	18

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	—	104	88	122	32	—	—	2	77	116
March 31, 2025	351	99	83	113	31	248	213	2	71	103
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.